1-1 of 1
Anju Singh, MD, MPH
Close
Sort by
Journal Articles

The Dark Side of NRF2: Upregulation of NRF2 as a Mechanism for Resistance to Imatinib In CML.

Dipika Gemani, MS, Lisa A Tobin, Anju Singh, MD, MPH, Maria R Baer, MD, Shyam Biswal, PhD, MS, Feyruz Rassool, PhD
Journal: Blood
Blood (2010) 116 (21): 3401.
https://doi.org/10.1182/blood.V116.21.3401.3401
Published: 2010